- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01748318
New Mexico Honey Wound Treatment Research Study
May 6, 2016 updated by: R. Stephen Rankin, M.D.
In a time of emerging bacteria that are resistant to antibiotics, honey offers an alternative that has potential to reduce the heavy reliance on pharmaceutical antibiotics.
We will be evaluating the effectiveness of a locally produced New Mexico Honey against the standard of care Bactrim antibiotic on Community Acquired MRSA.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Locally grown New Mexico Honey will be utilized on abscess wounds of the trunk and extremities vs routine (Bactrim) antibiotic care to determine if NM Honey is effective treatment for Community Acquired MRSA 6 cm abscesses.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Mexico
-
Farmington, New Mexico, United States, 87401
- Recruiting
- Pinon Family Practice
-
Contact:
- R Stephen Rankin, MD
- Phone Number: 505-324-1000
-
Principal Investigator:
- R Stephen Rankin, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 75 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 16 years of age or older
- Abscess less than or equal to 6 cm in diameter on the extremity or trunk requiring incision and drainage
- Patient willing to try honey prepared dressing
- Patient able to return to office each day for 7 days for evaluation
Exclusion Criteria:
- Under the age of 16
- Abscess of face, scalp or genitals
- Diagnosed as a diabetic
- Allergic to bee pollen, honey or sulfa antibiotics
- Diagnosed with peripheral vascular disease
- Patient acknowledgement of current drug or alcohol abuse
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: NM Regional Honey
15 ml of NM Honey applied directly to wound
|
Apply 15 ml of NM Honey to CA-MRSA Abscess compare to standard antibiotic treatment
Other Names:
Bactrim DS
Other Names:
|
|
Active Comparator: Bactrim DS
Standard of Care Oral Antibiotic
|
Apply 15 ml of NM Honey to CA-MRSA Abscess compare to standard antibiotic treatment
Other Names:
Bactrim DS
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Size of lesion at day 7
Time Frame: 7 days
|
Increase in size will determine failure; Decrease in size will determine success
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: R Stephen Rankin, MD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Anticipated)
May 1, 2018
Study Completion (Anticipated)
July 1, 2018
Study Registration Dates
First Submitted
December 10, 2012
First Submitted That Met QC Criteria
December 10, 2012
First Posted (Estimate)
December 12, 2012
Study Record Updates
Last Update Posted (Estimate)
May 10, 2016
Last Update Submitted That Met QC Criteria
May 6, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Gram-Positive Bacterial Infections
- Staphylococcal Infections
- Anti-Infective Agents
- Anti-Bacterial Agents
- Antiprotozoal Agents
- Antiparasitic Agents
- Antimalarials
- Anti-Infective Agents, Urinary
- Renal Agents
- Trimethoprim, Sulfamethoxazole Drug Combination
Other Study ID Numbers
- IND 115653
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community-acquired Methicillin-resistant Staphylococcus Aureus Infection
-
Ohio State UniversityCompletedMethicillin-resistant Staphylococcus Aureus | Methicillin-Sensitive Staphylococcus Aureus InfectionUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownMethicillin-Resistant Staphylococcus Aureus | ESBL InfectionIsrael
-
Sir Run Run Shaw HospitalUnknownMethicillin-resistant Staphylococcus Aureus | Community-Acquired InfectionsChina
-
Intron Biotechnology, Inc.CompletedHealthy Volunteers | Anti-Bacterial Agents | Methicillin-Resistant Staphylococcus Aureus | Methicillin-Sensitive Staphylococcus Aureus InfectionKorea, Republic of
-
VA Office of Research and DevelopmentCompletedMethicillin-Resistant Staphylococcus AureusUnited States
-
University of Colorado, DenverAmerican Academy of Family Physicians National Research NetworkCompletedMethicillin-Resistant Staphylococcus AureusUnited States
-
University Hospital, ToulouseCompletedMethicillin-Resistant Staphylococcus AureuS
-
University of Sao PauloUnknownMethicillin Resistant Staphylococcus AureusBrazil
-
University of PennsylvaniaChildren's Hospital of Philadelphia; Milton S. Hershey Medical Center; Pennsylvania...CompletedMRSA - Methicillin Resistant Staphylococcus Aureus InfectionUnited States
-
Massachusetts General HospitalTerminatedMRSA - Methicillin Resistant Staphylococcus Aureus InfectionUnited States
Clinical Trials on New Mexico Honey
-
Waiariki Institute of TechnologyManuka Health New ZealandCompleted
-
Pepperdine UniversityUniversity of California, Los AngelesCompleted
-
Fakultas Kedokteran Universitas IndonesiaCompletedOtitis Media, Suppurative | Tympanic Membrane PerforationIndonesia
-
Fakultas Kedokteran Universitas IndonesiaCompletedChronic Suppurative Otitis Media | Tympanic Membrane; WoundIndonesia
-
Postgraduate Medical Institute, LahoreCompleted
-
Ain Shams UniversityCompleted
-
Agricultural University of AthensCompletedAppetitive Behavior | Potential Abnormality of Glucose ToleranceGreece
-
Celal Bayar UniversityCompleted
-
Universiti Sains MalaysiaRecruitingDiabetes Mellitus | Diabetes | Wound Heal | HoneyMalaysia
-
Universiti Sains MalaysiaNot yet recruitingDry Eye Disease (DED) | Dry Eye Symptoms | Dry Eye Syndrome (DES)Malaysia